Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
114 EUR | +0.13% | -.--% | -.--% |
Apr. 11 | U.S. Futures Down, European Stocks Mixed | DJ |
Apr. 08 | DSM-Firmenich AG announces an Equity Buyback for 1,500,000 shares, representing 0.6% of its issued share capital. | CI |
Sales 2024 * | 12.69B 13.6B | Sales 2025 * | 13.34B 14.29B | Capitalization | 27.24B 29.19B |
---|---|---|---|---|---|
Net income 2024 * | 478M 512M | Net income 2025 * | 783M 839M | EV / Sales 2024 * | 2.38 x |
Net Debt 2024 * | 2.93B 3.14B | Net Debt 2025 * | 2.65B 2.84B | EV / Sales 2025 * | 2.24 x |
P/E ratio 2024 * |
57.2
x | P/E ratio 2025 * |
34.3
x | Employees | 28,685 |
Yield 2024 * |
2.39% | Yield 2025 * |
2.41% | Free-Float | 25.03% |
Latest transcript on Koninklijke DSM
1 day | +0.13% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 57 | 89-12-31 | |
Ralf Schmeitz
DFI | Director of Finance/CFO | - | 23-08-31 |
Sarah Reisinger
CTO | Chief Tech/Sci/R&D Officer | 45 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 63 | 23-01-31 | |
Thomas Leysen
CHM | Chairman | 63 | 23-01-31 |
Director/Board Member | 62 | 23-01-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
3.43% | 303 M€ | +12.09% | ||
1.13% | 18 M€ | +3.79% | - |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+12.70% | 876B | |
0.00% | 239B | |
+26.35% | 177B | |
-7.96% | 126B | |
+32.50% | 78.86B | |
-5.26% | 74.14B | |
-16.38% | 50.58B | |
-24.57% | 38.71B | |
+19.71% | 32.18B |
- Stock Market
- Equities
- DSFIR Stock
- DSM Stock